Mechanism of clobazam-induced thyroidal oncogenesis in male rats

Toxicology Letters

Volumn 145, Issue 3, 2003, Pages 291-301

  Miyawaki, Izuru ^a   Moriyasu, Matsuko ^b   Funabashi, Hitoshi ^a   Yasuba, Masashi ^a   Matsuoka, Nobuo ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^b Panapharm Laboratories Co Ltd   (Japan)

Author keywords

Benzodiazepine; Clobazam; T4 UDP glucuronosyltransferase; Thyroid hormone; Thyroidal oncogenesis; TSH

Indexed keywords

CLOBAZAM; GLUCURONOSYLTRANSFERASE; IODINE 125; LIOTHYRONINE; THYROTROPIN; THYROXINE; THYROXINE I 125; URIDINE DIPHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; HORMONE DETERMINATION; HORMONE SYNTHESIS; LIOTHYRONINE BLOOD LEVEL; LIVER HYPERTROPHY; LIVER WEIGHT; LONG TERM CARE; MALE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; RAT; RAT STRAIN; THYROID FOLLICLE CELL; THYROID FOLLICULAR CARCINOMA; THYROID HORMONE RELEASE; THYROID HORMONE SYNTHESIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ANIMALIA;

EID: 0142216462     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.08.002     Document Type: Article

References (34)

1. Anandam R. Clobazam in epilepsy. Indian J. Pediatr. 67(Suppl. 1):2000;88-91.
2. Beetstra J.B., Engelen J.G., Karels P., Hoek H.J., Jong M., Docter R., Krenning E.P., Hennemann G., Brouwer A., Visser T.J. Thyroxine and 3,3′,5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases. Endocrinology. 128:1991;741-746.
3. Comer C.P., Changelis C.P., Levin S., Kotsonis F.N. Changes in thyroidal function and liver UDPglucuronosyltransferase activity in rats following administration of a novel imidazole (SC-37211). Toxicol. Appl. Pharm. 80:1985;427-436.
4. Contin M., Riva R., Albani F., Baruzzi A.A. Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy. Ther. Drug Monit. 21:1999;604-608.
5. Contrera J.F., Jacobs A.C., DeGeorge J.J. Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals. Regul. Toxicol. Pharmacol. 25:1997;130-145.
6. 125I -labelled thyroxine glucuronide by reversed-phase high-performance liquid chromatography using on-line radiochemical detection to determine UDPglucuronosyltransferase activity J. Chromatogr. 566:1991;415-426.
7. Gregerman R.I. Estimation of thyroxine secretion rate in the rat by the radioactive thyroxine turnover technique: influences of age, sex and exposure to cold. Endocrinology. 72:1963;382-392.
8. Hewett C., Ellenberger J., Köllmer H., Kreuzer H., Niggeschulze A., Stötzer H. Safety assessment of brotizolam. Arzneimittel Forschung. 36:1986;592-596.
9. Hill R.N., Crisp T.M., Hurley P.M., Rosenthal S.L., Singh D.V. Risk assessment of thyroid follicular cell tumors. Environ. Health Perspect. 106:1998;447-457.
10. 3) glucuronidation. Toxicol. Sci. 55:2000;78-84.
11. Hood A., Hashmi R., Klaassen C.D. Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy. Toxicol. Appl. Pharmacol. 160:1999;163-170.
12. Kanno J., Matsuoka C., Furuta K., Onodera H., Miyajima H., Maekawa A., Hayashi Y. Tumor promoting effect of goitrogens on the rat thyroid. Toxicol. Pathol. 18:1990;239-246.
13. Klaassen C.D., Hood A.M. Effects of microsomal enzyme inducers on thyroid follicular cell proliferation and thyroid hormone metabolism. Toxicol. Pathol. 29:2001;34-40.
14. 35S ] methimazole in phenobarbital and thyroxine-treated rats Endocrinology. 100:1977;765-769.
15. Liu J., Liu Y., Barter R.A., Klaassen C.D. Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study. J. Pharmacol. Exp. Ther. 273:1995;977-985.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
17. Lu A.Y., Levin W. Partial purification of cytochromes P-450 and P-448 from rat liver microsomes. Biochem. Biophys. Res. Commun. 46:1972;1334-1339.
18. Mackenzie P.I., Owens I.S., Burchell B., Bock K.W., Bairoch A., Belanger A., Fournel-Gigleux S., Green M., Hum D.W., Iyanagi T., Lancet D., Louisot P., Magdalou J., Chowdhury J.R., Ritter J.K., Schachter H., Tephly T.R., Tipton K.F., Nebert D.W. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. 7(4):1997;255-269.
19. 4) and potassium iodide (KI) on the serum concentrations of thyrotrophin (TSH) and thyroid hormones in the rat. Acta Endocrinol. 91:1979;271-281.
20. McClain R.M. Thyroid gland neoplasia: non-genotoxic mechanisms. Toxicol. Lett. 64-65:1992;397-408.
21. McClain R.M. Mechanistic considerations for the relevance of animal data on thyroid neoplasia to human risk assessment. Mutat. Res. 333:1995;131-142.
22. McClain R.M., Levin A.A., Posch R., Downing J.C. The effect of phenobarbital on the metabolism and excretion of thyroxine in rats. Toxicol. Appl. Pharm. 99:1989;216-228.
23. ®), a new antiepileptic drug. Nippon Yakurigaku Zasshi. 118:2001;117-122. (in Japanese).
24. Nims R.W., Prough R.A., Jones C.R., Stockus D.L., Dragnev K.H., Thomas P.E., Lubet R.A. In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam. Drug Metab. Dispos. 25:1997;750-756.
25. Owen N.V., Griffing W.J., Hoffman D.G., Gibson W.R., Kiplinger G.F. Dichlorophenobarbital-induced centrilobular hypertrophy of hepatocytes and enzyme induction in the rat. Vet. Pathol. 12:1975;67-68.
26. Radvila A., Roost R., Burgi H., Kohler H., Studer H. Inhibition of thyroglobulin biosynthesis and degradation by excess iodide. Synergism with lithium. Acta Endocrinol. 81:1976;495-506.
27. Refetoff, S., Reed, L.P., 1989. Transport, cellular uptake and metabolism of thyroid hormones. In: Groot, L.D. (Ed.), Endocrinology I. Sunders, Philadelphia, pp. 541-561.
28. Remy C. Clobazam in the treatment of epilepsy: a review of the literature. Epilepsia. 35(Suppl. 5):1994;88-91.
29. Tukey R.H., Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 40:2000;581-616.
30. Vansell N.R., Klaassen C.D. Increased biliary excretion of thyroxine by microsomal enzyme inducers. Toxicol. Appl. Pharm. 176:2001;187-194.
31. Valente W.A., Vitti P., Kohn L.D., Brandi M.L., Rotella C.M., Toccafondi R., Tramontano D., Aloj S.M., Ambesi-Impiombato F.S. The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. Endocrinology. 112:1983;71-79.
32. 3) and its metabolites. Toxicol. Sci. 65:2002;184-191.
33. Visser T.J., Kaptein E., Gijzel A.L., de Herder W.W., Ebner T., Burchell B. Glucuronidation of thyroid hormone by human bilirubin and phenol UDP-glucuronyltransferase isoenzymes. FEBS Lett. 324:1993;358-360.
34. Yoshimura, I., 1987. Welch's test. In: Yoshimura, I. (Ed.), Statistical Analysis of Toxicological Data. Scientist Inc., Tokyo, pp. 32-35 (in Japanese).